Discussion on Director Li Peirun's Clinical Experience in Treating Precancerous Lesions of Gastric Cancer Based on the Theory of Targeted Differentiation
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v7i1.5052
Abstract
Precancerous lesions of gastric cancer are an important stage in the process of normal gastric mucosa developing into gastric cancer. This refers to a series of pathological changes such as atypical hyperplasia and intestinal metaplasia of gastric mucosal epithelial cells, which have a certain tendency for malignancy but have not yet developed into a state of gastric cancer. This study aims to deeply analyze the connotation of the theory of targeted differentiation and treatment, detail Director Li Peirun's strategies for differentiating and targeting precancerous lesions of gastric cancer, and showcase his diagnostic and therapeutic ideas and medication characteristics through clinical cases, providing innovative treatment examples and theoretical references for the field of gastric cancer, promoting the application of the theory of targeted differentiation and treatment in the prevention and treatment of precancerous lesions of gastric cancer, and laying a foundation for subsequent related research.
Keywords
targeted differentiation and treatment, precancerous lesions of gastric cancer, Li Peirun, experience of famous doctors
Full Text
PDF - Viewed/Downloaded: 2 TimesReferences
[1] Liu Tianshi, Yu Shanshan. Research Progress on Traditional Chinese Medicine Treatment for Gastric Precancerous Lesions [J]. Electronic Journal of Modern Medicine and Health Research, 2024, 8(21): 136-141.
[2] Zhang Shengsheng, Zhao Luqing. Expert Consensus on Diagnosis and Treatment of Chronic Gastritis in Traditional Chinese Medicine (2017) [J]. Journal of Chinese Medicine, 2017, 32(7): 3060-3064.
[3] Zhang Shengsheng, Liu Jixiang, Li Danyan, et al. Broad Prospects for Traditional Chinese Medicine Diagnosis and Treatment of Chronic Atrophic Gastritis and Gastric Precancerous Lesions [J]. Chinese Journal of Integrative Gastroenterology, 2024, 32(06): 461-468.
[4] Shi Xin, Li Yongjing, Cong Jun, et al. Analysis of Cai Gan's Experience in Treating Precancerous Gastric Lesions of Spleen Deficiency with Stagnant Heat from the Perspective of “State-Target Differentiation and Treatment” [J]. Shanghai Journal of Traditional Chinese Medicine, 2024, 58(06): 44-48.
[5] Song Bin. Exploring the Construction of a Diagnostic and Therapeutic System for Chronic Gastritis Based on the Theory of State-Target Differentiation and Treatment [J]. Journal of Changchun University of Chinese Medicine, 2024, 40(04): 377-380.
[6] Zhang Yufei, Li Liheng, Chen Changjin, et al. Advances in Pharmacological Mechanisms and Pharmacokinetics of Hedyotis diffusa in Antitumor Effects [J]. Journal of Traditional Chinese Medicine, 2025, 53(01): 111-117.
[7] Yan Baofei, Liu Shengjin, Mao Yibei, et al. Effects of Wild Baicalin on Regulating Wnt/β-Catenin Signaling Pathway in Modulating Migration and Invasion of Colon Cancer Cells [J]. Chinese Journal of New Drugs and Clinical Medicine, 2023, 42(05): 311-317.
[8] Ding Huwei, Zhang Ping, Sheng Hua, et al. Effects of Wild Baicalin on Gastric Cancer HGC-27 Cells and Regulation of Ferroptosis Mechanism [J]. Modern Chinese Medicine Research and Practice, 2024, 38(05): 39-45.
[9] Li Shao. Network Targets: An Entry Point for Network Pharmacology of Traditional Chinese Medicine Formulas [J]. Chinese Journal of Traditional Chinese Medicine, 2011, 36(15): 2017-2020.
[10] Li Ji, Zuo Zhengyun. Formulary Science [M]. Beijing: China Traditional Chinese Medicine Press, 2021:77.
[2] Zhang Shengsheng, Zhao Luqing. Expert Consensus on Diagnosis and Treatment of Chronic Gastritis in Traditional Chinese Medicine (2017) [J]. Journal of Chinese Medicine, 2017, 32(7): 3060-3064.
[3] Zhang Shengsheng, Liu Jixiang, Li Danyan, et al. Broad Prospects for Traditional Chinese Medicine Diagnosis and Treatment of Chronic Atrophic Gastritis and Gastric Precancerous Lesions [J]. Chinese Journal of Integrative Gastroenterology, 2024, 32(06): 461-468.
[4] Shi Xin, Li Yongjing, Cong Jun, et al. Analysis of Cai Gan's Experience in Treating Precancerous Gastric Lesions of Spleen Deficiency with Stagnant Heat from the Perspective of “State-Target Differentiation and Treatment” [J]. Shanghai Journal of Traditional Chinese Medicine, 2024, 58(06): 44-48.
[5] Song Bin. Exploring the Construction of a Diagnostic and Therapeutic System for Chronic Gastritis Based on the Theory of State-Target Differentiation and Treatment [J]. Journal of Changchun University of Chinese Medicine, 2024, 40(04): 377-380.
[6] Zhang Yufei, Li Liheng, Chen Changjin, et al. Advances in Pharmacological Mechanisms and Pharmacokinetics of Hedyotis diffusa in Antitumor Effects [J]. Journal of Traditional Chinese Medicine, 2025, 53(01): 111-117.
[7] Yan Baofei, Liu Shengjin, Mao Yibei, et al. Effects of Wild Baicalin on Regulating Wnt/β-Catenin Signaling Pathway in Modulating Migration and Invasion of Colon Cancer Cells [J]. Chinese Journal of New Drugs and Clinical Medicine, 2023, 42(05): 311-317.
[8] Ding Huwei, Zhang Ping, Sheng Hua, et al. Effects of Wild Baicalin on Gastric Cancer HGC-27 Cells and Regulation of Ferroptosis Mechanism [J]. Modern Chinese Medicine Research and Practice, 2024, 38(05): 39-45.
[9] Li Shao. Network Targets: An Entry Point for Network Pharmacology of Traditional Chinese Medicine Formulas [J]. Chinese Journal of Traditional Chinese Medicine, 2011, 36(15): 2017-2020.
[10] Li Ji, Zuo Zhengyun. Formulary Science [M]. Beijing: China Traditional Chinese Medicine Press, 2021:77.
Copyright © 2026 Ying Ma, Peirun Li, Jianhu Xu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License